mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal new junction evidence (lowest skew 10 of 12 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913 | = 2731579 | 54 (1.260) | 5 (0.130) | 5/262 | 5.0 | 9.0% | intergenic (‑422/+21) | rrsG/clpB | 16S ribosomal RNA of rrnG operon/protein disaggregation chaperone |
| ? | NC_000913 | = 2731583 | 51 (1.290) | intergenic (‑426/+17) | rrsG/clpB | 16S ribosomal RNA of rrnG operon/protein disaggregation chaperone | |||||
| * | ? | NC_000913 | 1465092 = | 46 (1.070) | 3 (0.080) | 3/262 | 6.2 | 7.1% | intergenic (+31/+73) | paaY/ynbG | thioesterase required for phenylacetic acid degradation; trimeric; phenylacetate regulatory and detoxification protein; hexapeptide repeat protein/uncharacterized protein |
| ? | NC_000913 | 1465125 = | 36 (0.910) | intergenic (+64/+40) | paaY/ynbG | thioesterase required for phenylacetic acid degradation; trimeric; phenylacetate regulatory and detoxification protein; hexapeptide repeat protein/uncharacterized protein | |||||
| * | ? | NC_000913 | 274620 = | NA (NA) | 3 (0.070) | 3/266 | 6.2 | NA | noncoding (530/1195 nt) | IS5 | repeat region |
| ? | NC_000913 | 274663 = | NA (NA) | noncoding (487/1195 nt) | IS5 | repeat region | |||||
| * | ? | NC_000913 | = 4537667 | 42 (0.980) | 3 (0.070) | 3/270 | 6.3 | 6.9% | coding (1099/1107 nt) | nanM | N‑acetylneuraminic acid mutarotase |
| ? | NC_000913 | = 4537697 | 41 (1.010) | coding (1069/1107 nt) | nanM | N‑acetylneuraminic acid mutarotase | |||||
| * | ? | NC_000913 | = 1954508 | NA (NA) | 3 (0.070) | 3/270 | 6.3 | NA | noncoding (80/98 nt) | RIP139 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP139 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site |
| ? | NC_000913 | = 1954519 | NA (NA) | noncoding (91/98 nt) | RIP139 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | RIP139 (repetitive extragenic palindromic) element; contains 2 REP sequences and 1 IHF site | |||||
| * | ? | NC_000913 | = 641354 | 51 (1.190) | 3 (0.070) | 3/270 | 6.3 | 6.3% | intergenic (+36/+85) | ahpF/uspG | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding/universal stress protein UP12 |
| ? | NC_000913 | = 641366 | 41 (1.010) | intergenic (+48/+73) | ahpF/uspG | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding/universal stress protein UP12 | |||||
| * | ? | NC_000913 | 4107580 = | 56 (1.310) | 4 (0.100) | 3/272 | 6.4 | 7.2% | coding (29/963 nt) | pfkA | 6‑phosphofructokinase I |
| ? | NC_000913 | 4107611 = | 50 (1.220) | coding (60/963 nt) | pfkA | 6‑phosphofructokinase I | |||||
| * | ? | NC_000913 | 3469435 = | 39 (0.910) | 3 (0.070) | 3/276 | 6.4 | 7.7% | coding (419/2694 nt) | chiA | periplasmic endochitinase |
| ? | NC_000913 | 3469452 = | 34 (0.820) | coding (402/2694 nt) | chiA | periplasmic endochitinase | |||||
| * | ? | NC_000913 | = 2868820 | 40 (0.930) | 3 (0.070) | 3/272 | 6.4 | 7.8% | intergenic (‑67/+73) | nlpD/pcm | activator of AmiC murein hydrolase activity, lipoprotein/L‑isoaspartate protein carboxylmethyltransferase type II |
| ? | NC_000913 | = 2868830 | 33 (0.800) | intergenic (‑77/+63) | nlpD/pcm | activator of AmiC murein hydrolase activity, lipoprotein/L‑isoaspartate protein carboxylmethyltransferase type II | |||||
| * | ? | NC_000913 | 2666016 = | 41 (0.960) | 3 (0.070) | 3/276 | 6.4 | 6.8% | coding (582/1281 nt) | csiE | stationary phase inducible protein |
| ? | NC_000913 | 2666038 = | 43 (1.030) | coding (604/1281 nt) | csiE | stationary phase inducible protein | |||||